drugset / Trial / NCT02152228

A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism

NCT02152228

Phase 2 Completed 20 enrolled Entera Bio Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This is an observational, international, open label, pilot study to evaluate the safety, tolerability and efficacy of an oral PTH (1-34) preparation produced by Entera Bio in adult hypoparathyroid volunteers.

Timeline

Start
2014-07
Primary completion
2015-06
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Teriparatide Protein / enzyme biologic Oral

Indications